These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37106085)

  • 21. How bans on germline editing deprive patients with mitochondrial disease.
    Cohen IG; Adashi EY; Ravitsky V
    Nat Biotechnol; 2019 Jun; 37(6):589-592. PubMed ID: 31110356
    [No Abstract]   [Full Text] [Related]  

  • 22. Current and Emerging Clinical Treatment in Mitochondrial Disease.
    Tinker RJ; Lim AZ; Stefanetti RJ; McFarland R
    Mol Diagn Ther; 2021 Mar; 25(2):181-206. PubMed ID: 33646563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions.
    Mustafa MF; Fakurazi S; Abdullah MA; Maniam S
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32059522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Editing: A View Through the Prism of Inherited Metabolic Disorders.
    Davison J
    New Bioeth; 2018 Apr; 24(1):2-8. PubMed ID: 29529978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition, investigation and management of mitochondrial disease.
    Davison JE; Rahman S
    Arch Dis Child; 2017 Nov; 102(11):1082-1090. PubMed ID: 28647693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a therapy for mitochondrial disease.
    Viscomi C
    Biochem Soc Trans; 2016 Oct; 44(5):1483-1490. PubMed ID: 27911730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current progress in the therapeutic options for mitochondrial disorders.
    Koňaříková E; Marković A; Korandová Z; Houštěk J; Mráček T
    Physiol Res; 2020 Dec; 69(6):967-994. PubMed ID: 33129249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current advances in gene therapy of mitochondrial diseases.
    Soldatov VO; Kubekina MV; Skorkina MY; Belykh AE; Egorova TV; Korokin MV; Pokrovskiy MV; Deykin AV; Angelova PR
    J Transl Med; 2022 Dec; 20(1):562. PubMed ID: 36471396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapies in inborn errors of oxidative metabolism.
    Schiff M; Bénit P; Jacobs HT; Vockley J; Rustin P
    Trends Endocrinol Metab; 2012 Sep; 23(9):488-95. PubMed ID: 22633959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of exogenous DNA to mitochondria in skeletal muscle following hydrodynamic limb vein injection.
    Yasuzaki Y; Yamada Y; Kanefuji T; Harashima H
    J Control Release; 2013 Dec; 172(3):805-11. PubMed ID: 24100263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks inherent to mitochondrial replacement.
    Morrow EH; Reinhardt K; Wolff JN; Dowling DK
    EMBO Rep; 2015 May; 16(5):541-4. PubMed ID: 25807984
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicine. Transatlantic lessons in regulation of mitochondrial replacement therapy.
    Cohen IG; Savulescu J; Adashi EY
    Science; 2015 Apr; 348(6231):178-80. PubMed ID: 25859028
    [No Abstract]   [Full Text] [Related]  

  • 33. Emerging aspects of treatment in mitochondrial disorders.
    Rahman S
    J Inherit Metab Dis; 2015 Jul; 38(4):641-53. PubMed ID: 25962587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges.
    Falabella M; Minczuk M; Hanna MG; Viscomi C; Pitceathly RDS
    Nat Rev Neurol; 2022 Nov; 18(11):689-698. PubMed ID: 36257993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial Matchmaking.
    Chinnery PF; Zeviani M
    N Engl J Med; 2016 Nov; 375(19):1894-1896. PubMed ID: 27959648
    [No Abstract]   [Full Text] [Related]  

  • 36. [MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].
    Furukawa R; Yamada Y; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1389-98. PubMed ID: 23208046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.
    Tanaka M; Borgeld HJ; Zhang J; Muramatsu S; Gong JS; Yoneda M; Maruyama W; Naoi M; Ibi T; Sahashi K; Shamoto M; Fuku N; Kurata M; Yamada Y; Nishizawa K; Akao Y; Ohishi N; Miyabayashi S; Umemoto H; Muramatsu T; Furukawa K; Kikuchi A; Nakano I; Ozawa K; Yagi K
    J Biomed Sci; 2002; 9(6 Pt 1):534-41. PubMed ID: 12372991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in mitochondrial DNA and approaches for their correction.
    Patrushev MV; Kamenski PA; Mazunin IO
    Biochemistry (Mosc); 2014 Nov; 79(11):1151-60. PubMed ID: 25540000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.
    Peralta S; Torraco A; Iommarini L; Diaz F
    Mitochondrion; 2015 Jul; 23():71-80. PubMed ID: 25638392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical and legal issues in mitochondrial transfer.
    Newson AJ; Wilkinson S; Wrigley A
    EMBO Mol Med; 2016 Jun; 8(6):589-91. PubMed ID: 27137493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.